Skip to main content

Reactions Weekly

Ausgabe 1/2016

October 29, 2016

Inhalt (194 Artikel)

Case report

Adalimumab

Case report

Afatinib

Case report

Afatinib

Case report

Afatinib

Case report

Afatinib

Case report

Alectinib

Case report

Alemtuzumab

Case report

Alteplase

Case report

Alteplase

Case report

Alteplase

Case report

Amiodarone

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antituberculars

Case report

Antituberculars

Case report

Antituberculars

Case report

Azathioprine

Case report

BCG

Case report

Beclometasone

Case report

Betamethasone

Case report

Bevacizumab

Case report

Biotin

Case report

Calcium acetate

Case report

Canagliflozin

Case report

Capecitabine

Case report

Capreomycin

Case report

Carbon dioxide

Case report

Carboplatin

Case report

Carboplatin/etoposide

Case report

Caspofungin

Case report

Celecoxib

Case report

Ciprofloxacin

Case report

Cisplatin

Case report

Clindamycin

Case report

Clozapine

Case report

Clozapine

Case report

Colistin/tigecycline

Case report

Corticotropin

Case report

Cotrimoxazole

Case report

Crizotinib

Case report

Crizotinib

Case report

Cyclophosphamide

Case report

Danazol

Case report

Delamanid

Case report

Desogestrel

Case report

Dexamethasone

Case report

Dexamethasone

Case report

Dexamethasone

Case report

Docetaxel

Case report

Docetaxel

Case report

Enbucrilate

Case report

Enoxaparin sodium

Case report

Enoxaparin sodium

Case report

Epinephrine

Case report

Epinephrine

Case report

Erlotinib

Case report

Estrogen

Case report

Etoposide

Case report

Everolimus

Case report

Flutamide

Case report

Gefitinib

Case report

Gemcitabine

Case report

Glatiramer acetate

Case report

Glimepiride

Case report

Heparin

Case report

Heparin

Case report

Ibuprofen

Case report

Idarubicin

Case report

Idarucizumab

Case report

Imatinib

Case report

Imatinib

Case report

Imipenem/meropenem

Case report

Imiquimod

Case report

Infliximab

Case report

Infliximab

Case report

Infliximab

Case report

Infliximab

Case report

Interferon-α-2a

Case report

Iodine-125

Case report

Ipilimumab

Case report

Ledipasvir/sofosbuvir

Case report

Lenvatinib

Case report

Levodopa

Case report

Lidocaine

Case report

Medroxyprogesterone

Case report

Melphalan

Case report

Metformin

Case report

Methadone

Case report

Methotrexate

Case report

Methotrexate

Case report

Methotrexate

Case report

Micafungin

Case report

Minocycline

Case report

Morphine

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Natalizumab

Case report

Neratinib

Case report

Nilotinib

Case report

Octreotide

Case report

Ofatumumab

Case report

Olanzapine

Case report

Olanzapine

Case report

Olmesartan medoxomil

Case report

Oxaliplatin

Case report

Paroxetine

Case report

Pazopanib

Case report

Pembrolizumab

Case report

Polygonum multiflorum

Case report

Povidone iodine

Case report

Prednisolone

Case report

Prednisone

Case report

Prednisone

Case report

Prednisone/warfarin

Case report

Pregabalin

Case report

Propranolol

Case report

Propranolol

Case report

Regorafenib

Case report

Rituximab

Case report

Rituximab

Case report

Ropivacaine

Case report

RRx-001

Case report

Sodium chloride

Case report

Sugammadex

Case report

Sultiame

Case report

Thorium dioxide

Case report

Ticagrelor

Case report

Tobramycin

Case report

Trastuzumab

Case report

Triamcinolone

Case report

Triflusal

Case report

Valproic acid

Case report

Valproic acid

Case report

Vandetanib

Case report

Vincristine

Case report

Voriconazole

Case report

Warfarin

Case report

Yellow fever vaccine

Case report

Yttrium 90

Case report

Zoledronic acid